Euromed SA Partners with Biotherapeutics Inc. to Launch the First Abscisic Acid Nutritional Ingredient to Market

Euromed leads the way in seeking and finding ingredient innovation that addresses broad-based health concerns for consumers globally, stated Euromed SA’s CEO Javier Roig.

Two innovative companies are bringing to market an exciting nutritional ingredient that is not only entirely new and different, it is scientifically proven as well: ABAlife™. Euromed SA, a leading manufacturer of therapeutic botanical extracts, announced today that the company has received an exclusive license agreement with BioTherapeutics Inc. for patented technology for absiscic acid (ABA).

The patents licensed by Euromed are entitled: “Method of using abscisic acid to treat diseases and disorders” (Patent numbers 7,741,1367 and 8,367,727, and the Inventors are Josep Bassaganya-Riera, Raquel Hontecillas, and Amir Guri). The invention relates to biologically active compounds (ABA) that treat and prevent insulin resistance and impaired glucose tolerance. The patents provide protection for structure-function claims related to ABA and maintenance of healthy blood sugar levels and similar statements.

By partnering with BioTherapeutics, “Euromed continues to seek ingredient innovation that will address broad-based health concerns for consumers globally,” commented Javier Roig CEO of Euromed S.A. “ABAlife™, our trade name for this ingredient can provide a safe and effective dietary supplement to aid in correcting impaired carbohydrate metabolism.”

“We are looking forward to partner with Euromed to accelerate the development of new ABA-containing nutritional products for glycemic control,” said Josep Bassaganya-Riera, President and CEO of BioTherapeutics. “We anticipate that the first product containing ABAlife™ will be a functional health water to be launched in the U.S. market under the Pervida® brand. The Pervida brand is currently commercializing Pervida Immune for gut and immune health, and in 2018 it will launch Pervida Control, the first ABA-containing beverage for glycemic control.”

The average American consumes 19.5 teaspoons of sugar every day. That quantity adds up to 66 pounds of added sugar consumed per person every year. Sugar increases the level of glucose in the blood and causes the pancreas to release insulin. Higher insulin…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *